Rockwell Medical, Inc. provided financial guidance for the year 2023. For the period, the company expects net sales to be between $82.0 million and $86.0 million, which represents an increase of 17% to 18% year-over-year.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.465 USD | +0.69% | -3.30% | -22.49% |
Apr. 17 | Rockwell Medical Continues to Expand Its Distribution Capabilities in Western United States | CI |
Apr. 04 | Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.49% | 42.73M | |
+25.92% | 661B | |
+26.74% | 566B | |
-6.52% | 352B | |
+20.39% | 332B | |
+3.13% | 283B | |
+13.45% | 231B | |
+4.70% | 200B | |
-9.41% | 195B | |
-5.11% | 145B |
- Stock Market
- Equities
- RMTI Stock
- News Rockwell Medical, Inc.
- Rockwell Medical, Inc. Provides Financial Guidance for the Year 2023